Skip to content

AbInitio Bio

YC X26 · Active · The Intelligence layer for Drug Manufacturing

Competitors

Adjacent

Also from X26 in AI

All of X26

Founders

  • Daniel MukasaFounder/CEO
  • Nisha GopalFounder

About AbInitio Bio

Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.

YC batch
X26 · Spring 2026
Status, per YC
Active
Category
AI
Team size
2
Location
Boston, MA, USA
Founded
2026
Checked
35m ago

AbInitio Bio in X26: 193 companies, 84% AI

LinkedIn

AbInitio Bio: questions

Which YC batch was AbInitio Bio in?

AbInitio Bio was in Y Combinator's Spring 2026 batch (X26).

Is AbInitio Bio still active?

Y Combinator lists AbInitio Bio as active.

Who founded AbInitio Bio?

AbInitio Bio's founders, as listed on its YC page: Daniel Mukasa (Founder/CEO), Nisha Gopal (Founder).

Where is AbInitio Bio based?

AbInitio Bio lists Boston, MA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.